US 11390861
CRISPR/cas-related methods and compositions for treating herpes simplex virus
granted A61PA61P31/22
Quick answer
US patent 11390861 (CRISPR/cas-related methods and compositions for treating herpes simplex virus) held by Editas Medicine, Inc. expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P31/22